This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jarnagin, W. R. Articles by Singh, B. Search for Related Content PubMed PubMed Citation Articles by Jarnagin, W. R. Articles by Singh, B. Social Bookmarking                            What's this?

Differential Cell Cycle–Regulatory Protein Expression in Biliary Tract Adenocarcinoma: Correlation With Anatomic Site, Pathologic Variables, and Clinical Outcome

From the Departments of Surgery, Pathology, and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY

Address reprint requests to William R. Jarnagin, MD, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021; e-mail: jarnagiw{at}mskcc.org

PURPOSE: Biliary tract adenocarcinomas (BTAs), although anatomically related, arise through ill-defined and possibly different location-related pathogenetic pathways. This clinicopathologic study characterizes differences in cell cycle–regulatory protein expression across the spectrum of BTA.

METHODS: Tissue microarrays were prepared from paraffin-embedded surgical specimens with triplicate cores of BTA and benign tissue. Immunohistochemical expression of p53, cyclin D1, p21, Bcl2, p27, Mdm2, and Ki-67 was assessed, and the results were correlated with pathologic variables and survival. Hierarchical clustering was used to partition the data based on protein expression, and then the data were analyzed according to anatomic location.

RESULTS: Tissue from 128 surgical patients (1992 to 2002) was obtained. Tumor sites of origin were intrahepatic cholangiocarcinoma (IH; n = 23), hilar cholangiocarcinoma (Hilar; n = 54), gallbladder (GB; n = 32), and distal bile duct (Distal; n = 19). p27 expression decreased progressively from proximal to distal in the biliary tree and correlated with location-related differences in outcome; cyclin D1 and Bcl2 overexpression also varied according to anatomic site. Aberrant p53 staining and cyclin D1 overexpression were lower in papillary tumors compared with the more common sclerosing tumors. The expression profiles of GB and Hilar were more similar to each other than either was to IH or Distal (86% clustering in the first partition). After an R0 resection, overexpression of Mdm2 (P = .0062) and absent p27 expression (P = .0165) independently predicted poor outcome.

CONCLUSION: BTAs differentially express cell cycle–regulatory proteins based on tumor location and morphology. Prognostic roles were identified for Mdm2 and p27. Overlap in the pathogenesis of GB and Hilar tumors was suggested.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				Y.-C. Shen, F.-C. Hu, Y.-M. Jeng, Y.-T. Chang, Z.-Z. Lin, M.-C. Chang, C. Hsu, and A.-L. Cheng Nuclear Overexpression of Mitotic Regulatory Proteins in Biliary Tract Cancer: Correlation with Clinicopathologic Features and Patient Survival Cancer Epidemiol. Biomarkers Prev., February 1, 2009; 18(2): 417 - 423. [Abstract] [Full Text] [PDF]

				W.-B. Kim, H.-J. Han, H.-j. Lee, S.-S. Park, T.-J. Song, H.-K. Kim, S.-O. Suh, Y.-C. Kim, and S.-Y. Choi Expression and Clinical Significance of Cell Cycle Regulatory Proteins in Gallbladder and Extrahepatic Bile Duct Cancer Ann. Surg. Oncol., January 1, 2009; 16(1): 23 - 34. [Abstract] [Full Text] [PDF]

				T. Sano, K. Shimada, Y. Sakamoto, H. Ojima, M. Esaki, and T. Kosuge Prognosis of Perihilar Cholangiocarcinoma: Hilar Bile Duct Cancer versus Intrahepatic Cholangiocarcinoma Involving the Hepatic Hilus Ann. Surg. Oncol., February 1, 2008; 15(2): 590 - 599. [Abstract] [Full Text] [PDF]